EU/India drugs seizure dispute not resolved yet
This article was originally published in Scrip
After the initial euphoria over reports that India and the EU may have settled their dispute concerning the seizure of transiting Indian consignments of generic medicines at EU ports, it now appears that a final resolution of the matter could still be some time away.
You may also be interested in...
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.
Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…